Healthcare & Life Sciences
Spero Therapeutics
Spero Therapeutics is a Healthcare & Life Sciences startup based in All, since gone public, 1 tracked investor.
stubipo
ipo
Stage
2014
Founded
1
Investors
About Spero Therapeutics
Based in All, Spero Therapeutics is a startup founded in 2014. Its most recent tracked round is IPO. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Spero Therapeutics develops differentiated medicines for patients with rare diseases and multidrug-resistant bacterial infections. The company is developing an investigational oral carbapenem (tebipenem HBr) for complicated urinary tract infections and works with external partners (e.g., GSK).
Explore Spero Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.